Association of elevated serum ferritin levels and the risk of gestational diabetes mellitus in pregnant women: The Camden study

Diabetes Care

Volumn 29, Issue 5, 2006, Pages 1077-1082

  Chen, Xinhua ^a   Scholl, Theresa O ^a   Stein, T Peter ^a  

^a UMDNJ School of Osteopathic Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FERRITIN;

ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; INFLAMMATION; MATERNAL AGE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PREPREGNANCY CARE; PROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

EID: 33746337326     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0164     Document Type: Article

References (33)

1. Harrison PM, Arosio P: The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275:161-203, 1996
2. Torti FM, Torti SV: Regulation of ferritin genes and protein. Blood 99:3505-3516, 2002
3. Lipschitz DA, Cook JD, Finch CA: A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 290:1213-1216, 1974
4. Kaneshige E: Serum ferritin as an assessment of iron stores and other hematologic parameters during pregnancy. Obstet Gynecol 57:238-242, 1981
5. Kalantar-Zadeh K, Rodriguez RA, Humphreys MH: Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrol Dialysis Transplant 19:141-149, 2004
6. Lim MK, Lee CK, Ju YS, Cho YS, Lee MS, Yoo B, Moon HB: Serum ferritin as a serologic marker of activity in systemic lupus erythematosus. Rheumatol Int 20:89-93, 2001
7. Ramakrishnan U, Kuklina E, Stein AD: Iron stores and cardiovascular disease risk factors in women of reproductive age in the United States. Am J Clin Nutr 76:1256-1260, 2002
8. Gillum RF: Association of serum ferritin and cardiovascular risk factors: a cross-sectional analysis of data from the third National Health and Nutrition Examination Survey [article online], 2005. Available from http://www.ispub.com/ ostia/index.php?xmlFilePath=journals/ije/archives.xml. Accessed 14 October 2005
9. Fernandez-Real JM, Lopez-Bermejo A, Ricart W: Cross-talk between iron metabolism and diabetes. Diabetes 51:2348-2354, 2002
10. Tuomainen TP, Nyyssonen K, Salonen R, Tervahauta A, Korpela H, Lakka T, Kaplan GA, Salonen JT: Body iron stores are associated with serum insulin and blood glucose concentrations: population study in 1,013 eastern Finnish men. Diabetes Care 20:426-428, 1997
11. Fernandez-Real JM, Ricart-Engel W, Casamitjana-Abella R, Cabrero D, Arroyo E, Fernandez-Castaner M, Balanca R, Soler J: Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 21:62-68, 1998
12. Ford ES, Cogswell ME: Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care 22:1978-1983, 1999
13. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB: Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 291:711-717, 2004
14. Williams MJA, Poulton R, Williams S: Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. Atherosclerosis 165:179-184, 2002
15. Mainous AG III, Wells BJ, Everett CJ, Gill JM, King DE: Association of ferritin and lipids with C-reactive protein. Am J Cardiol 93:559-562, 2004
16. American Diabetes Association: Gestational diabetes mellitus. Diabetes Care 23 (Suppl 1):S77-S79, 2000
17. Clark CM, Qiu C, Amerman B, Porter B, Fineberg N, Aldasouqi S, Golichowski A: Gestational diabetes: should it be added to the syndrome of insulin resistance? Diabetes Care 20:867-871, 1997
18. Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R: First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 26:819-824, 2003
19. Qiu C, Sorensen TK, Luthy DA, Williams MA: A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinatal Epidemiol 18:377-384, 2004
20. Kriketos AD, Greenfield JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA, Campbell LV: Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects. Diabetes Care 27:2033-2040, 2004
21. Lao TT, Tam KF: Maternal serum ferritin and gestational impaired glucose tolerance. Diabetes Care 20:1368-1369, 1997
22. Lao TT, Chan PL, Tam KF: Gestational diabetes mellitus in the last trimester - a feature of maternal iron excess? Diabet Med 18:218-223, 2001
23. Hughes JW, Seneca JJ: Ranking the Municipalities, a Rutgers Regional Report. New Brunswick, NJ, Center for Urban Policy Research, 1994
24. Hediger ML, Scholl TO, Schall JI, Healey MF, Fischer RL: Changes in maternal upper arm fat stores are predictors of variation in infant birth weight. J Nutr 124:24-30, 1994
25. Institute of Medicine: Iron nutrition during pregnancy. In Nutrition During Pregnancy, Weight Gain and Nutrient Supplements. Washington, DC, National Academies Press, 1990, p 272-298
26. Knuiman MW, Divitini ML, Olynyk JK, Cullen DJ, Bartholomew HC: Serum ferritin and cardiovascular disease: a 17-year follow-up study in Busselton, Western Australia. Am J Epidemiol 158:144-149, 2003
27. Wilson JG, Lindquist JH, Grambow SC, Crook ED, Maher JF: Potential role of increased iron stores in diabetes. Am J Med Sci 325:332-339, 2003
28. Salonen JT, Tuomainen TP, Nyyssonen K, Lakka HM, Punnonen K: Relation between iron stores and non-insulin dependent diabetes in men: case control study. BMJ 317:727, 1998
29. Lao TT, Chan LY, Tam KF, Ho LF: Maternal hemoglobin and risk of gestational diabetes mellitus in Chinese women. Obstet Gynecol 99:807-812, 2002
30. Lao TT, Ho LF: Impact of iron deficiency anemia on prevalence of gestational diabetes mellitus. Diabetes Care 27:650-656, 2004
31. Mandato C, Lucariello S, Licenziati MR, Franzese A, Spagnuolo MI, Ficarella R, Pacilio M, Amitrano M, Capuano G, Meli R, Vajro P: Metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease. J Pediatr 147:62-66, 2005
32. Sacks GP, Seyani L, Lavery S, Trew G: Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum Reprod 19:1025-1030, 2004
33. Retnakaran R, Hanley AJG, Raif N, Connelly PW, Sermer M, Zinman B: C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 88:3507-3512, 2003